Purpose: It has been proposed that changes in the permeability of Bruch's membrane play a role in the pathogenesis of age-related macular degeneration (AMD). This paper investigates, in an in vivo porcine model, the migration of fluorescent latex beads across the Bruch's membrane after subretinal injection. Methods: Forty-one healthy eyes of 33 three-month-old domestic pigs received a subretinal injection of 0.5, 1.0, 2.0, or 4.0 μm fluorescent latex beads. Between three hours and five weeks after injection evaluations were performed with fundus photographs and histology. Fluorescent beads were identified in unstained histologic sections using the rhodamine filter with the light microscope. Results: The fluorescent latex beads relocated from the subretinal space. Intact beads up to 2.0 μm were found in the choroid, sclera, and extrascleral space. The smaller beads were also found inside choroidal and extrascleral blood vessels. In contrast, the larger beads of 4.0 μm did not pass the Bruch's membrane. Conclusion: Subretinally implanted beads up to 2.0 μm pass the Bruch's membrane intact and cross the bloodocular barrier. The intact beads are found in the choroid, sclera and inside blood vessels. The results give reason to consider the role of subretinal clearance and passage of Bruch's membrane in the development of AMD.
Introduction
Bruch's membrane is a 5-layered structure that serves as basal membrane for both the retinal pigment epithelium (RPE) and choriocapillaris. Studies have shown that accumulation of deposits in BM precedes age-related macular degeneration (AMD) (Algvere et al., 2016; Zarbin, 2004) . These deposits have been thought to cause congestion of the BM and thereby cause decreased transport of material across BM leading to disease (Hussain et al., 2010) . The mechanism of transport across BM is, however, not very well understood.
It is well documented that the RPE is capable of transporting fluid (Sparrow et al., 2010) and removing shed photoreceptor outer segments through phagocytosis (Bok, 1993; Sparrow et al., 2010) . Tight intercellular junctions between the RPE cells (Marmor, 1979) and apical and basal specialized transport proteins (Boulton and Dayhaw-Barker, 2001; Frambach and Marmor, 1982; Marmor et al., 1980; Negi and Marmor, 1986 ) maintain the subretinal volume and composition (Boulton and Dayhaw-Barker, 2001; Hamann, 2002; Sparrow et al., 2010; Wimmers et al., 2007) . Fluid is transported across RPE cells through aquaporins (Sparrow et al., 2010) and experimentally it has been shown that saline is absorbed within hours after subretinal injection (Frambach and Marmor, 1982; Marmor, 1988; Marmor et al., 1980) . Transport of nutrients such as glucose, fatty acids (Strauss, 2005) , and amino acids (Miyamoto and Del Monte, 1994; Pautler and Tengerdy, 1986) from the blood to the photoreceptors is also regulated by the RPE. However, this regulation must also involve the Bruch's membrane, as the membrane is located between the choriocapillaris and the RPE.
Knowledge of the passage of Bruch's membrane is limited to in vitro studies of smaller molecules. In vitro it has been shown that the membrane's hydraulic conductivity (Lee et al., 2015) and permeability for lipids (Cankova et al., 2011) decreases with age. Furthermore, in vitro studies have also shown that the Bruch's membrane slows down the passage of model proteins from the choriocapillaris to the RPE (Tratta et al., 2014) . Diffusion of small molecules (< 1.0-6.15 nm) across the Bruch's membrane has also been described in vivo (ZayasSantiago et al., 2011) .
In the present study, we report how larger elements of various sizes and up to 4 μm in diameter are taken up by the RPE in an in vivo porcine model. Beads up to 2 μm then pass Bruch's membrane and are found intact in the choroid, sclera, extraocular tissues, and inside blood vessels.
Methods
The research protocol complied with the ARVO Statement on the Use of Animals in Ophthalmic and Vision Research and was approved by the Danish Animal Experiments Inspectorate (Permission-number 2012 (Permission-number -15-2934 . A veterinarian supervised all animal procedures.
Animals and anesthesia
The study included 41 healthy eyes of 33 three-month-old female domestic pigs of Danish Landrace/Duroc/Hampshire/Yorkshire breed weighing approximately 25 kg at inclusion. Eight pigs were operated on in both eyes; and due to ethical reasons, none of the pigs were allowed to survive surgery on the second eye. RPE cells labeled with 0.5 μm fluorescent beads (#F8887, FluoSpheres™, Life Technologies, Eugene, Oregon, USA) were injected into the subretinal space in 12 left eyes. Fluorescent beads of 0.5, 1.0, 2.0, or 4.0 μm (#F8887 and #F8858, FluoSpheres™, Life Technologies, Eugene, Oregon, USA) were injected subretinally into 41 eyes of 33 pigs.
The pigs were enucleated for histology at different time points after injection ( Table 1 ). The number of animals and evaluation time differ among the groups, as the experiments were conducted in three steps. In
Step 1, 0.5 μm beads were injected into the subretinal space and evaluated weeks after surgery (N = 7, Table 1 ). Few beads were found in
Step 1 and evaluation time in Step 2 was shortened from weeks to hours or days and bead sizes increased up to 2.0 μm (N = 22, Table 1 ). The beads were easily identified in Step 2 and the study was expanded with evaluation weeks after injection of beads > 0.5 μm in Step 3 (N = 12, Table 1 ).
Eighteen hours prior to anesthesia, the animals were fasted but had free access to water. The animals were pre-anesthetized and both pupils were dilated as previously described (Sorensen et al., 2013) . After endotracheal intubation, the pigs were artificially ventilated with 0.5 l/ min 100% oxygen and 2.5 l/min atmospheric air. The stroke volume (10 ml/kg) and respiratory frequency (16/min) were kept constant. Through the endotracheal tube, isoflurane 2.5-3.0% (Attane vet, ScanVet Animal Health A/S) was administered with 100% oxygen. Animals were hydrated with intravenous saline (Fresenius Kabi 9 mg/ ml) and covered with a blanket that ensured a stable body temperature of 38-39°C. Heart rate, electrocardiogram (ECG), temperature and carbon dioxide and oxygen saturation levels were monitored. If ocular stabilization was insufficient, an intravenous injection of 1 ml neuromuscular blocker (2 mg/ml Nimbex ® , GlaxoSmithKline Pharma A/S, Brøndby, Denmark) was administered.
Evaluation and surgical procedure
Prior to surgery, fundus photographs were obtained by a Zeiss FF450 plusIR (Carl Zeiss, Jena, Germany) . In all eyes, a three-port vitrectomy followed by a localized posterior vitreous detachment was performed.
The fluorescent beads (one size per eye) were diluted with isotonic saline (1:200, Fresenius Kabi 9 mg/ml) and 0.2 ml was injected into the subretinal space through a 41 G needle (ref. 1270.01, DJ Instrumenter, Denmark) , causing a retinal detachment bleb. For the experiments with short follow-up (three to six hours), the untreated fellow eye (right) was used and underwent surgery at the final evaluation day; the pigs were kept anesthetized during the entire procedure. For the remaining experiments, the animals were awakened after surgery and re-anesthetized for follow-up.
The number of beads per mL were calculated with the following equation from the products datasheet: beads/mL= (6C*10 12) / (ρ*π*φ 3)
), where: C = concentration of suspended beads in g/mL (0.02 g/mL for our 2% suspensions), φ = diameter of microspheres in μm, ρ = density in g/mL (in this product 1.05). Thus, in 1 ml of the product with 0.5 μm beads there were: (6 × 0.02 × 10 12 )/ (1.05 × 3.14 × 0.5 3 ) = 2.9 × 10 11 beads/ml. As previously mentioned the product was diluted 1:200 and 0.2 ml of the dilution was then injected, the number of injected 0.5 μm beads was therefore ((2. At the final examination day, in full anesthesia, fundus images were obtained (Zeiss FF450 plusIR, Carl Zeiss, Jena, Germany) and fentanyl (Hameln pharmaceuticals GmbH, 50 μg/ml) 5 μg/kg was injected intravenously and the eyes removed for histology. The anesthetized pigs were then euthanized as previously described (Sorensen et al., 2012) .
Histology
The location of the beads was examined histologically after enucleation. In vivo examination with ocular coherence tomography (OCT) was not performed, as the OCT has a resolution of 2 μm and above and therefore do not allow for single bead detection.
The enucleated eyes were fixed in paraformaldehyde 4% and either embedded in paraffin (34 eyes) or cryosectioned (7 eyes). The two different preparation methods were used in order to exclude destruction of beads during paraffin embedding procedures. Segments containing the optic disc and the bleb area were isolated and sections of 5 μm were cut through the lesion. To exclude mechanical displacement of beads by the knife during the sectioning process, the frozen specimen was alternately cut from the vitreal and the scleral side. All paraffin embedded specimens were cut from the same side. Every other section was stained with hematoxylin and eosin (H & E stain). The fluorescent beads could only be identified in the unstained sections using the rhodamine filter (551 nm/573 nm, Carl Zeiss, Jena, Germany) with the light microscope (Axioplan 2, Carl Zeiss, Jena, Germany). Digital images were obtained with an Axiocam HRC (Carl Zeiss, Jena, Germany) as previously described (Lassota et al., 2007) .
All histological evaluation was performed in a masked fashion. All specimens were evaluated by fluorescence angiography and histology for presence of a choroidal neovascularization (CNV) as a sign of a breach in the Bruch's membrane (Lassota et al., 2007) . All unstained sections were examined for the presence of beads in specific layers ( Table 2 ). The homogenous 1 μm group was then semi-quantitatively scored, as its distribution pattern was representative for the 0.5 μm and Table 1 The distribution of eyes by bead size and evaluation time.
The table shows the number of animals for each bead size distributed in three different steps:
Step 1 = white, Step 2 = light grey, and Step 3 = dark grey. N.B. Sørensen et al. Experimental Eye Research 180 (2019) 1-7 2.0 μm groups (Table 3 ). The 4 μm group, which had a different distribution pattern, was also semi-quantitatively scored (Table 4) . For semi-quantitative analysis, six sections located at a distance of 20 μm, 50 μm, and 100 μm in each direction from the injection site were scored and the average number of beads given in Tables 3 and 4 For analysis of phagocytic cells, one representative section from each animal was stained with macrophage markers CD68PGM-R (Agilent, anti-CD68, Alkaline Phosphatase, #M087601), CD68PGM1 M1 (Agilent, anti-CD68, DAB, #M087601) and CD68KP1 M1 (Roche, CONFIRM™ anti-CD68 (KP-1), # 790-2931). For analysis of location of beads in relation to RPE, one representative section from each animal was stained with epithelia marker CK-AECAM M1 (Biocare Medical, Pan Cytokeratin Plus [AE1/AE3+8/18], #CM162A, B, C).
Results
The injected fluorescent beads relocated from the subretinal space (Figs. 1-4 , Tables 2-4). Neither the cutting direction of the histological sections (from scleral or vitreous side) nor the preservation method influenced the distribution of the beads. Independent of size, beads could be found in the retina and intravitreally in all specimens (Fig. 1 ). As it was not possible to determine whether the beads had actually passed through the retina or simply entered through the retinotomy, the distribution in these two layers has not been analyzed further. None of the animals experienced a retinal detachment after the initial bleb. There were no signs of CNV's in any of the histological specimens and accordingly the Bruch's membrane has been intact in all eyes.
Distribution of beads up to 2 μm
A few hours after injection, beads up to the size of 2 μm were found intact in the choroid, sclera, and extrascleral spaces (Table 2, Fig. 1 ). The beads were also observed inside phagocytic cells residing in the subretinal space, intravitreally, and in the extrascleral space (Fig. 1) . The three different macrophage markers did not stain these phagocytic cells.
Some beads were observed inside choroidal and extrasclearal blood vessels (Fig. 3) .
Distribution of 4 μm beads
One week after injection, the larger 4.0 μm beads were primarily found in the subretinal space (Fig. 4) . Two weeks after injection, the majority of the beads were found in the RPE/resting on Bruch's membrane (Figs. 4 and 5) .
The fluorescent beads could not be identified in the histologic sections stained with the RPE marker CK-AECAM M1. For evaluation of location of beads in relation to RPE, an unstained neighbor section was therefore superimposed on the stained section (Fig. 5) .
None of the 4.0 μm beads were observed in the layers beneath Bruch's membrane (i.e., choroid, sclera, and extrascleral spaces) (Tables  2 and 4) . A considerably higher number of 4.0 μm beads were found in both the subretinal space and RPE weeks after subretinal injection (Table 4 ) compared to the smaller beads (Table 3) .
Discussion
We demonstrate that beads up to 2 μm in diameter pass the Bruch's membrane in vivo and can be found intact in the choroid, sclera and extrascleral tissues in porcine eyes. On a biological scale, 2 μm equals the size of shed photoreceptor outersegments (POS) (Fig. 6) .
With increasing time after injection, the number of beads in the subretinal space decreases. It could be speculated that this decrease is caused by simple degradation of the beads in the subretinal space. However, beads ≤2.0 μm are found intact in the choroid and the sclera at various times after injection. Even though this does not exclude that some beads are degraded in the subretinal space, it shows that intact beads are relocated from the subretinal space across the RPE/Bruch's membrane.
One possible explanation for this relocation could be mechanical Each specimen scored 1 if one or more beads were found in the layer and 0 if none were found; the maximum score in each layer is, therefore, equal to the number of eyes in the group.
Table 3
The relationship between the number of 1 μm beads in specific layers and time after injection.
Time Number of eyes Subretinal RPE Bruch's membrane Choroid Sclera Extra-scleral 3 h 3 **** *** * * * * 6 h 5 **** *** * * * ** 1-2 weeks 5 * ** * * * * ****≥ 100 beads, *** = 50-99 beads, ** = 10-49 beads, * = 1-9 beads.
Table 4
The number of 4 μm beads in the specific layers 1-2 weeks after injection.
Time Number of eyes Subretinal RPE Bruch's membrane Choroid Sclera Extra-scleral 1-2 weeks 4 ** ** *** 0 0 0 ****≥ 100 beads, *** = 50-99 beads, ** = 10-49 beads, * = 1-9 beads.
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displacement of the beads ex-vivo, in the cutting process of the histological specimens. In theory, the beads could have been pressed out of the subretinal space by the knife used in the preparation of histological specimens. The specimens were alternately cut from the vitreal and the scleral side and independent of cutting direction, the beads were found in the choroid, sclera and extra scleral space. Mechanical displacement of the beads is therefore unlikely as an explanation of intact beads in the choroid and beyond. The time-related decrease of beads in the subretinal space also emphasize that relocation of beads must happen in the living animal. It could be speculated that the beads could escape the subretinal space through micro-ruptures in the Bruch's membrane induced by the subretinal surgery. Such a breach in the Bruch's membrane would have induced a choroidal neovascularization (CNV) (Lassota et al., 2007) . There were no CNVs in any of our histological specimens, and we therefore conclude that there were no breaches in the Bruch's membrane. The beads must therefore have passed an intact Bruch's membrane.
The beads are also found intact in choroidal and extra-scleral blood vessels. It could therefore be speculated that the beads did not pass the Bruch's membrane, but left the subretinal space through the retinal blood vessels. We cannot entirely exclude that this happened, but it seems unlikely. If the beads reached the sclera and the choroid through the systemic circulation, they would first have to enter the retinal vessels, pass the systemic circulation and then leave the choroidal and extrascleral vessels. Such a route of distribution is not likely to deliver the observed quantities of beads in the choroid and sclera after subretinal injection. Our observations of beads just at the junction between Bruch's membrane and the choroid further support that passage of the RPE/Bruch's membrane takes place. Fig. 1 . Fundus photographs and corresponding micrographs of porcine retinal sections shortly after subretinal injection of 0.5 μm beads (red spheres). A) Fundus photograph taken six hours after subretinal injection shows a bleb filled with pink 0.5 μm fluorescent beads (arrow). B) Twenty-four hours after injection, only a few 0.5 μm beads can be seen as pink areas on the fundus photograph (arrow). C) A micrograph from six hours after injection shows 0.5 μm beads in the subretinal space (upper arrow), in the choroid (arrow with asterisk), and sclera (lower two arrows). D) Twenty-four hours after injection, a micrograph shows 0.5 μm beads intravitreally (upper arrow) and in the subretinal space (lower arrow). The area inside the small rectangle corresponds to the area in the big rectangle, where large round phagocytic cells with several beads inside can be seen. These phagocytic cells can be seen in the micrograph both in the subretinal space and intravitreally (upper and lower arrows). GCL = ganglion cell layer, INL = inner nuclear layer, ONL = outer nuclear layer, PRL = photoreceptor layer, SRS = subretinal space, RPE = retinal pigment epithelium, and BM = Bruch's membrane. With increasing time after injection, the number of beads found in the subretinal space decreased (Fig. 2, Table 3 ). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) Fig. 2 . Micrographs of porcine retinal sections at different time points after subretinal injection of 1.0 μm fluorescent beads. A) Six hours after injection, the fluorescent beads (arrows) are primarily found in the enlarged subretinal space. B) After seven days, the distance between the PRL and RPE has decreased and beads (arrows) are still found in the subretinal space. C) After 14 days, there are almost no beads left in the subretinal space; the bead in the picture is inside an RPE cell (arrow). GCL = ganglion cell layer, INL = inner nuclear layer, ONL = outer nuclear layer, PRL = photoreceptor layer, SRS = subretinal space, RPE = retinal pigment epithelium, and BM = Bruch's membrane. N.B. Sørensen et al. Experimental Eye Research 180 (2019) 1-7 Given the structure of the RPE (Bok, 1993; Cunha-Vaz, 1976; Rizzolo, 1997; Stalmans and Himpens, 1997; Strauss, 2005) it is surprising that elements as large as 2 μm can pass. As the paracellular resistance of the RPE is 10 times higher than the transcellular (Miller and Steinberg, 1977a, b) , the beads most likely pass through the RPEcells. This assumption is supported by our findings of beads inside RPE cells, which have also been observed by others (Kolko et al., 2007) . The RPE is capable of phagocytosis and this process could explain how the beads are internalized in the cells.
The regulation of phagocytosis in the RPE has been thoroughly reviewed (Kevany and Palczewski, 2010) and different receptors involved in the process have been identified (Chang and Finnemann, 2007; Hall et al., 1996; Lin and Clegg, 1998; Ryeom et al., 1996; Sun et al., 2006; Tarnowski et al., 1988) . One of the important findings is the transmembrane tyrosine kinase receptor MerTK (D'Cruz et al., 2000; Finnemann and Nandrot, 2006; Sparrow et al., 2010) , which is responsible for internalization of the photoreceptor's outer segments. However, it would be surprising if the receptor had affinity for nonorganic beads and another method for initiation of phagocytosis is therefore more likely. RPE-cells without the MerTK receptor have been Fig. 3 . Micrograph of beads inside a porcine extrascleral blood vessel. In the picture, two 0.5 μm beads (arrows) can be seen inside a large extrascleral vessel. In the lower part of the micrograph, the bead is seen in a cluster of red blood cells (*). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) shown to perform nonspecific phagocytosis (Edwards and Szamier, 1977) . It is therefore possible that the presence of beads in the subretinal space initiates removal through the RPE by nonspecific phagocytosis.
The present study indicates that the transport mechanism across RPE/Bruch's membrane is limited by size. While the beads ≤2.0 μm are found in the choroid and sclera shortly after subretinal injection, the 4 μm beads are halted by the RPE/Bruch's membrane for at least two weeks. Our results showed no 4 μm beads in the choroid or beyond. It should be noted that fewer 4 μm beads than 0.5 μm beads were injected (5.6 × 10 4 versus 2.9 × 10 11 ). However, the reduced number of injected beads cannot explain the different distribution pattern, as it is the proportion of beads in the different compartments that changes. It thus seems likely the passage over RPE/Bruch's membrane is limited to elements ≤2.0 μm. The passage of smaller beads through Bruch's membrane could be either passive or active. Passive transportation would involve that the beads could penetrate Bruch's membrane without damaging the structure. The Bruch's membrane is rich in elastin and exhibits elastic properties that decreases with aging (Booij et al., 2010) . Thus, it is possible that the membrane can allow passage of molecules up to a certain size, at least in young individuals. With increasing age, the loss of elastic properties in Bruch's membrane could therefore compose a limitation in the passage of Bruch's membrane. Such a limitation in the passage of the Bruch's membrane would lead to accumulation of waste material in the subretinal space and adjacent structures. Drusen in AMD could therefore represent waste material retained by a rigid Bruch's membrane. Aging of Bruch's membrane should therefore be considered in the development of drusen in AMD.
Active transportation of the beads across the Bruch's membrane would require a dedicated cell in the choroid that could enter the sub-RPE space. Such a phagocytic cell communicating with the sub-RPE space has been identified by Duvall et al.(Duvall and Tso, 1985) . It is possible that this cell plays a role in the relocation of the beads from the sub-RPE space. The fast passage of smaller beads through the choroid and sclera indicates active transportation, which would require a cellular mechanism. The aid of a cellular mechanism is also a likely explanation for our finding of beads in the choroidal and extrascleral blood vessels. Unfortunately, in the unstained sections where the beads are visualized, individual cells cannot be distinguished from compact tissue. No cells in the choroid or sclera were stained with the macrophage markers used in this study. Neither were the large round phagocytic cells filled with beads, located adjacent to retinal blood vessels, in the subretinal space, and in the extrascleral space stained with the macrophage markers.
The identity of the phagocytic cells filled with fluorescent beads observed in this study remains unknown. These cells were not stained with the RPE marker and it is therefore not likely that they represent activated RPE cells. Neither were the phagocytic cells stained with the human macrophage markers. This finding is inconclusive since the complete absence of macrophages in the porcine eye seems unlikely. Development of specific markers for macrophages in domestic pigs of Danish Landrace/Duroc/Hampshire/Yorkshire breed is beyond the scope of this study. We recommend that future porcine studies include electron-microscopy for examination of cellular transportation from the subretinal space.
The finding of beads inside choroidal and extrascleral blood vessels emphasize that subretinal implanted material can reach the systemic circulation. Future studies should be designed to include evaluation of systemic transport and clearance by samples of the urine and spleen.
Conclusion
In young, healthy eyes intact molecules smaller than 4 μm can pass the RPE cell and the Bruch's membrane. Future studies should examine the transport mechanism and possible changes in the passage of Bruch's membrane induced by aging.
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